{"chebi_id":"68610","chebi_name":"linagliptin","chebi_synonyms":["8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione","Tradjenta","BI 1356","(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione"],"diffprof_id_observed":["MTBLS2871_0001_00000009"],"diffprof_id_var_observed":["MTBLS2871_0001_00000009"],"inchikey":"LTXREWYXXSTFRX-QGZVFWFLSA-N","inn_name":"linagliptin","iupac_name":"8-[(3<i>R</i>)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1<em>H</em>-purine-2,6-dione","num_study_observed":1,"reactome_ids":["R-HSA-2980736","R-HSA-381771","R-HSA-392499","R-HSA-400508"],"reactome_names":["Peptide hormone metabolism","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","Metabolism of proteins","Incretin synthesis, secretion, and inactivation"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":["MTBLS2871"],"synonym_name":"(<i>R</i>)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione"}